All Stories

  1. Vitamin D (1,25(OH)2D3) induces α-1-antitrypsin synthesis by CD4+ T cells, which is required for 1,25(OH)2D3-driven IL-10
  2. High-Dose IL-2 Skews a Glucocorticoid-Driven IL-17+IL-10+ Memory CD4+ T Cell Response towards a Single IL-10–Producing Phenotype
  3. Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter
  4. Exogenous sex steroid hormones and asthma in females: protocol for a population-based retrospective cohort study using a UK primary care database
  5. Vitamin D in Asthma
  6. Vitamin D supplementation during pregnancy: Effect on the neonatal immune system in a randomized controlled trial
  7. Dendritic cell phenotype in severe asthma reflects clinical responsiveness to glucocorticoids
  8. Urban particulate matter stimulation of human dendritic cells enhances priming of naive CD8 T lymphocytes
  9. Vitamin D Counteracts an IL-23–Dependent IL-17A+IFN-γ+ Response Driven by Urban Particulate Matter
  10. Addressing unmet needs in understanding asthma mechanisms
  11. Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responses
  12. Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei
  13. ASTHMA – comparing the impact of vitamin D versus UVR on clinical and immune parameters
  14. Urban Particulate Matter–Activated Human Dendritic Cells Induce the Expansion of Potent Inflammatory Th1, Th2, and Th17 Effector Cells
  15. Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years
  16. 1α,25-dihydroxyvitamin D3 acts via transforming growth factor-βto up-regulate expression of immunosuppressive CD73 on human CD4+Foxp3-T cells
  17. Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol
  18. A comparative phase 1 clinical trial to identify anti-infective mechanisms of vitamin D in people with HIV infection
  19. Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33
  20. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3supplementation in adults with asthma (ViDiAs)
  21. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial
  22. Vitamin D Influences Asthmatic Pathology through Its Action on Diverse Immunological Pathways
  23. Developments in the field of allergy in 2013 through the eyes of Clinical and Experimental Allergy
  24. Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease
  25. 1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-βincreases the frequency of Foxp3+regulatory T cells through preferential expansion and usage of interleukin-2
  26. The effects of calcitriol treatment in glucocorticoid-resistant asthma
  27. Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma
  28. Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3
  29. Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma
  30. Urban Particulate Matter Suppresses Priming of Th1 Cells by GM-CSF-Activated Human Dendritic Cells
  31. Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion
  32. Vitamin D and Asthma in Children
  33. Vitamin D and lung disease
  34. The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+and IL-10+CD4+T cells
  35. Serum 25-dihydroxyvitamin D levels correlate with CD4+Foxp3+ T-cell numbers in moderate/severe asthma
  36. T cells producing the anti-inflammatory cytokine IL-10 regulate allergen-specific Th2 responses in human airways
  37. Glucocorticosteroids Are Potential Confounders in Studies of Vitamin D and Asthma: Reply
  38. Vitamin D binding protein and asthma severity in children
  39. 1α,25-Dihydroxyvitamin D3 promotes CD200 expression by human peripheral and airway-resident T cells
  40. Vitamin D and Regulatory T Cells
  41. Relationship between Serum Vitamin D, Disease Severity, and Airway Remodeling in Children with Asthma
  42. A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*
  43. Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes
  44. A direct role for vitamin D-binding protein in the pathogenesis of COPD?
  45. The Impact of Vitamin D on Regulatory T Cells
  46. A novel technique to explore the functions of bronchial mucosal T cells in chronic obstructive pulmonary disease: application to cytotoxicity and cytokine immunoreactivity
  47. Regulatory T cells, inflammation and the allergic response—The role of glucocorticoids and Vitamin D
  48. Asthma and allergy: The early beginnings
  49. Vitamin D, the immune system and asthma
  50. Regulatory T Cells in Asthma
  51. Vitamin D and Asthma
  52. Counter regulation of the high affinity IgE receptor, FcεRI, on human airway dendritic cells by IL-4 and IL-10
  53. Regulatory T cells in bronchial asthma
  54. Ligation of TLR9 induced on human IL-10–secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory function
  55. Strategies for use of IL-10 or its antagonists in human disease
  56. Role of cysteinyl leukotrienes in human allergen-specific Th2 responses induced by granulocyte macrophage-colony stimulating factor
  57. The glucocorticoid receptor β isoform can mediate transcriptional repression by recruiting histone deacetylases
  58. Regulatory T cell therapy as individualized medicine for asthma and allergy
  59. Plasmacytoid Dendritic Cells from Human Lung Cancer Draining Lymph Nodes Induce Tc1 Responses
  60. Immunological intervention in human diseases
  61. Interleukin-10-Secreting regulatory T cells in allergy and asthma
  62. Regulatory T cells in human disease and their potential for therapeutic manipulation
  63. Vitamin D3 in inflammatory airway disease and immunosuppression
  64. T regulatory cells and the control of allergic disease
  65. Effector Cells of Allergy
  66. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients
  67. Regulatory T cells and IL-10 in allergic inflammation: Figure. 1.
  68. Functional plasticity of human respiratory tract dendritic cells: GM-CSF enhances TH2 development
  69. Interleukin-10–Secreting “Regulatory” T Cells Induced by Glucocorticoids and β2-Agonists
  70. Repression ofInterleukin-5Transcription by the Glucocorticoid Receptor Targets GATA3 Signaling and Involves Histone Deacetylase Recruitment
  71. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma
  72. Targeting the dendritic cell: the key to immunotherapy in cancer?
  73. Glucocorticoid-resistant asthma
  74. Impaired secretion of interleukin-4 and interleukin-13 by allergen-specific T cells correlates with defective nuclear expression of NF-AT2 and jun B: relevance to immunotherapy
  75. In Vitro Generation of Interleukin 10–producing Regulatory CD4+T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines
  76. A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients
  77. CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3+ T cells
  78. Discussion session II: Inflammation
  79. Monocytes and macrophages - friend or foe?
  80. Regulation of major histocompatibility complex class II antigens on human alveolar macrophages by granulocyte-macrophage colony-stimulating factor in the presence of glucocorticoids
  81. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
  82. Leflunomide Inhibits Pyrimidinede NovoSynthesis in Mitogen-stimulated T-lymphocytes from Healthy Humans
  83. A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection
  84. T-cell receptor peptides that inhibit the T-cell response to allergen induce transforming growth factor-β production
  85. Inhibition of human T-cell responses to house dust mite allergens by a T-cell receptor peptide
  86. Viewpoint: A Potential Role for Platelet Derived Cytokines in the Inflammatory Response
  87. Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not interferon gamma (IFN-γ) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytes
  88. Cell-cycle control in lymphocyte stimulation
  89. Human spleen cells mediating natural killing: Altered natural cytotoxicity of spleen effector cells from patients with carcinoma
  90. Depressed spontaneous natural killing and interferon augmentation in patients with malignant lymphoma
  91. Regulatory T Cells and Other Tolerogenic Mechanisms in Allergy and Asthma